Related Experiment Videos
Phase II study of ifosfamide (Holoxan) in hepatoma
S Thongprasert1, K Klunklin, K Phornphutkul
1Department of Internal Medicine, Chiang Mai University, Thailand.
European Journal of Cancer & Clinical Oncology
|November 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2005
Treatment of myelodysplastic syndrome with low-dose human granulocyte colony-stimulating factor: a multicenter study.
International journal of hematology·2001
Combination of gemcitabine and cisplatin in advanced non-small cell lung cancer.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet·2001
Protective effects of fosfomycin on cisplatin-induced nephrotoxicity in patients with lung cancer.
International journal of clinical pharmacology and therapeutics·2001
The role of exogenous hormones in the epidemiology of breast, ovarian and endometrial cancer.
European journal of cancer & clinical oncology·1989
Nutritional factors and cancers of the breast, endometrium and ovary.
European journal of cancer & clinical oncology·1989
Reproductive factors and cancers of the breast, ovary and endometrium.
European journal of cancer & clinical oncology·1989
Multiple primary cancers of the breast, endometrium and ovary.
European journal of cancer & clinical oncology·1989
Cancers of the breast, endometrium and ovary: geographic correlations.
European journal of cancer & clinical oncology·1989
Hormone replacement therapy in women treated for breast cancer.
European journal of cancer & clinical oncology·1989